Local analgesia during flexible cystoscopy in male patients : A non-inferiority study comparing Xylocaine® gel to Instillagel® Lido
Copyright © 2016 Elsevier Masson SAS. All rights reserved..
INTRODUCTION: Local anesthesia using urethral gel has been proven to reduce discomfort of male patients during flexible cystoscopy. This study was a non-inferiority study between two lidocain-containing urethral gel (Instillagel® Lido and Xylocaine® gel).
METHODS: A prospective single center study was conducted between June 2014 and November 2014. Male patients seen in the office and in whom a flexible cystoscopy was planned were included in the present study and received urethral instillation of either Xylocaine® gel or Instillagel® Lido at least 5minutes before flexible cystoscopy. No other anesthetic agent was used. Primary endpoint was pain during the procedure, assessed through visual analog scale (VAS) from 0 to 10.
RESULTS: Four hundred and sixty-one men were included: 233 in the Instillagel® Lido group and 228 in the Xylocaine® gel group. Indications of flexible cystoscopy non-muscle invasive bladder cancer follow-up in 44 % of cases, hematuria work-up in 21 % of cases and lower urinary tract symptoms work-up in 35 %. Patients' age was comparable betwwen both groups: 64.5 years (±1.1) in the Instillagel® Lido group and 66.2 years (±1.1) in the Xylocaine® gel group (P=0.29). The mean VAS was 0.8 (±0.1) in the Instillagel® Lido group and 0.6 (±0.1) in the Xylocaine® gel group (P=0.10). The non-inferiority criterion was reached (P<0.001) as the average difference in VAS between the two groups was 0.2 with a confidence interval not comprising 1 (CI 97.5 %: -0.47; 0.07).
CONCLUSION: In this prospective study, Instillagel® Lido was not inferior to Xylocaine® gel for local analgesia during flexible cystoscopy in male patients.
LEVEL OF EVIDENCE: 4.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 26(2016), 11-12 vom: 20. Sept., Seite 651-655 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Anesthésie locale pour fibroscopie chez l’homme : étude de non-infériorité comparant le Xylocaine® gel à l’Instillagel® Lido |
---|
Beteiligte Personen: |
Peyronnet, B [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 07.07.2017 Date Revised 07.07.2017 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.purol.2016.09.049 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM265073707 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM265073707 | ||
003 | DE-627 | ||
005 | 20231224211502.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/j.purol.2016.09.049 |2 doi | |
028 | 5 | 2 | |a pubmed24n0883.xml |
035 | |a (DE-627)NLM265073707 | ||
035 | |a (NLM)27712912 | ||
035 | |a (PII)S1166-7087(16)30556-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Peyronnet, B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Local analgesia during flexible cystoscopy in male patients |b A non-inferiority study comparing Xylocaine® gel to Instillagel® Lido |
246 | 3 | 3 | |a Anesthésie locale pour fibroscopie chez l’homme : étude de non-infériorité comparant le Xylocaine® gel à l’Instillagel® Lido |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.07.2017 | ||
500 | |a Date Revised 07.07.2017 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 Elsevier Masson SAS. All rights reserved. | ||
520 | |a INTRODUCTION: Local anesthesia using urethral gel has been proven to reduce discomfort of male patients during flexible cystoscopy. This study was a non-inferiority study between two lidocain-containing urethral gel (Instillagel® Lido and Xylocaine® gel) | ||
520 | |a METHODS: A prospective single center study was conducted between June 2014 and November 2014. Male patients seen in the office and in whom a flexible cystoscopy was planned were included in the present study and received urethral instillation of either Xylocaine® gel or Instillagel® Lido at least 5minutes before flexible cystoscopy. No other anesthetic agent was used. Primary endpoint was pain during the procedure, assessed through visual analog scale (VAS) from 0 to 10 | ||
520 | |a RESULTS: Four hundred and sixty-one men were included: 233 in the Instillagel® Lido group and 228 in the Xylocaine® gel group. Indications of flexible cystoscopy non-muscle invasive bladder cancer follow-up in 44 % of cases, hematuria work-up in 21 % of cases and lower urinary tract symptoms work-up in 35 %. Patients' age was comparable betwwen both groups: 64.5 years (±1.1) in the Instillagel® Lido group and 66.2 years (±1.1) in the Xylocaine® gel group (P=0.29). The mean VAS was 0.8 (±0.1) in the Instillagel® Lido group and 0.6 (±0.1) in the Xylocaine® gel group (P=0.10). The non-inferiority criterion was reached (P<0.001) as the average difference in VAS between the two groups was 0.2 with a confidence interval not comprising 1 (CI 97.5 %: -0.47; 0.07) | ||
520 | |a CONCLUSION: In this prospective study, Instillagel® Lido was not inferior to Xylocaine® gel for local analgesia during flexible cystoscopy in male patients | ||
520 | |a LEVEL OF EVIDENCE: 4 | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Anesthesia | |
650 | 4 | |a Anesthésie | |
650 | 4 | |a Cystoscopie | |
650 | 4 | |a Cystoscopy | |
650 | 4 | |a Gel | |
650 | 4 | |a Homme | |
650 | 4 | |a Male | |
650 | 4 | |a Urethra | |
650 | 4 | |a Urètre | |
650 | 7 | |a Anesthetics, Local |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a Gels |2 NLM | |
650 | 7 | |a chlorhexidine gluconate, lidocaine drug combination |2 NLM | |
650 | 7 | |a 8060-72-8 |2 NLM | |
650 | 7 | |a Lidocaine |2 NLM | |
650 | 7 | |a 98PI200987 |2 NLM | |
650 | 7 | |a Chlorhexidine |2 NLM | |
650 | 7 | |a R4KO0DY52L |2 NLM | |
700 | 1 | |a Drouin, S-J |e verfasserin |4 aut | |
700 | 1 | |a Gomez, F-D |e verfasserin |4 aut | |
700 | 1 | |a Seisen, T |e verfasserin |4 aut | |
700 | 1 | |a Goujon, A |e verfasserin |4 aut | |
700 | 1 | |a Pradere, B |e verfasserin |4 aut | |
700 | 1 | |a Bitker, M-O |e verfasserin |4 aut | |
700 | 1 | |a Phé, V |e verfasserin |4 aut | |
700 | 1 | |a Rouprêt, M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie |d 1997 |g 26(2016), 11-12 vom: 20. Sept., Seite 651-655 |w (DE-627)NLM012649481 |x 1166-7087 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2016 |g number:11-12 |g day:20 |g month:09 |g pages:651-655 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.purol.2016.09.049 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2016 |e 11-12 |b 20 |c 09 |h 651-655 |